PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q4 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $193,383 | -75.6% | 92,087 | -66.8% | 1.31% | -73.5% |
Q2 2023 | $792,197 | -73.6% | 276,992 | -73.1% | 4.95% | -54.1% |
Q1 2023 | $2,998,842 | -0.9% | 1,030,530 | -0.3% | 10.77% | +30.2% |
Q4 2022 | $3,027,071 | +22.1% | 1,033,130 | 0.0% | 8.27% | +90.0% |
Q3 2022 | $2,480,000 | +623.0% | 1,033,130 | +574.7% | 4.35% | +681.1% |
Q2 2022 | $343,000 | -2.6% | 153,130 | 0.0% | 0.56% | +21.9% |
Q1 2022 | $352,000 | -8.1% | 153,130 | 0.0% | 0.46% | +26.6% |
Q4 2021 | $383,000 | – | 153,130 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ayrton Capital LLC | 1,033,130 | $3,027,071 | 8.27% |
K2 PRINCIPAL FUND, L.P. | 732,105 | $2,145,068 | 0.33% |
EQUITEC PROPRIETARY MARKETS, LLC | 330,694 | $968,933 | 0.31% |
SABBY MANAGEMENT, LLC | 97,978 | $287,076 | 0.25% |
FNY Investment Advisers, LLC | 31,100 | $90 | 0.13% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 40,800 | $119,544 | 0.02% |
Aspire Private Capital, LLC | 800 | $2,344 | 0.00% |
Schonfeld Strategic Advisors LLC | 25,200 | $73,836 | 0.00% |
OSAIC HOLDINGS, INC. | 1,758 | $6,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 98 | $286 | 0.00% |